• Policy
• Korea-US gov't pledge to strengthen biohealth cooperation
• by Lee, Jeong-Hwan May 31, 2024 05:51am

• Company
• Delay after delay…When will Phesgo be reimb in Korea?
• by Eo, Yun-Ho May 31, 2024 05:51am

• Policy
• Research on reforming post-management of pharmaceuticals
• by Lee, Tak-Sun May 30, 2024 05:50am

• Opinion
• [Reporter’s View] We don’t know the fate of rivoceranib
• by Kim, Jin-Gu May 30, 2024 05:50am

• Company
• Over 50,000 ppl signed 2nd petition for Trodelvy’s reimb
• by Eo, Yun-Ho May 30, 2024 05:50am

• Policy
• MSD discontinues supply of Zostavax in Korea
• by Lee, Hye-Kyung May 30, 2024 05:50am

• Company
• 11 years since global entry…K-biosimilars
• by Chon, Seung-Hyun May 29, 2024 05:45am

• Company
• Six pharmaceutical companies challenge the 'Esgliteo' patent
• by Kim, Jin-Gu May 29, 2024 05:45am

• Company
• High-dose Eylea is approved in KOR
• by Son, Hyung-Min May 29, 2024 05:45am

• Company
• 'Camzyos' anticipated for the DREC review consideration
• by Eo, Yun-Ho May 29, 2024 05:45am